The UK drug discovery informatics market is estimated to grow significantly of 8.7% during the forecast period. The major factors that propel the market growth in the country include the rising demand of analytics tool in pharmaceutical R&D, growing adoption of cloud-based solutions by the pharmaceutical companies, significant investment by the pharmaceutical companies for the installation of drug discovery analytics tools in the country. The use of cloud technology facilitates a cost-effective, innovative and streamlined R&D process in the pharmaceutical industry. Therefore, high investment in R&D activities in the pharmaceutical industry in UK is anticipated to propel the growth of the drug discovery informatics market

The UK drug discovery informatics market is segmented on the basis of function and end-user. Based on the technology, the market is further classified into docking, molecular modeling, libraries & database preparation, sequencing & target data analysis, and others. The sequencing & target data analysis segment is projected to have considerable growth during the forecast period. Based on the end-user, the UK drug discovery informatics market is further segmented into pharmaceutical & biotechnology companies, contract research organizations, and others. The pharmaceutical & biotechnology companies segment is estimated to have a significant share in the market. 

Furthermore, the UK drug discovery informatics market is characterized by the presence of several market players that are catering to a wide range of customers in the region. Some of the key players in the market include Accenture PLC, Dassault Systèmes SE, Eurofins GSC Lux SARL, Evotec SE, Selvita S.A, and others. These players adopt various strategies to remain competitive in the market and gain a competitive advantage over other players operating in the market. Mergers and acquisitions, product launches, and partnerships and collaborations, and geographical expansion are some of the major activities adopted by the market players. 

Research Methodology

The market study of the UK drug discovery informatics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for drug discovery analytics market players, contract research organizations, biotechnology and pharmaceutical companies, industry associates & experts, government organizations, regulatory bodies, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. UK Drug Discovery Informatics Market Research and Analysis by Function
2. UK Drug Discovery Informatics Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of the UK drug discovery informatics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the UK drug discovery informatics market.
• Insights about market determinants that are stimulating the UK drug discovery informatics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.